This content is machine translated Viral hepatitis Hepatitis ABC(EN): Prophylaxis and treatment – an update In the acute stage of viral hepatitis, the clinical picture is similar for all five pathogens. HBV and HCV infections are the most dangerous chronic infectious diseases worldwide. In contrast…
View Post 3 min This content is machine translated Hepatitis C therapy Hepcare – a structured approach to successful treatment Family physicians play a key role in the elimination of hepatitis. The hepatitis C therapies available today are uncomplicated and, since the beginning of this year, can be prescribed in…
View Post 4 min This content is machine translated Hepatitis C Curable nowadays, but still underdiagnosed Due to the highly effective antivirals currently available on the market, the chances of cure are very high. However, if left untreated, hepatitis C infection can have serious consequences. The…
View Post 6 min This content is machine translated Liver disease Focus on the most common hepatopathies While modern pharmacotherapies are now available for hepatitis B and C, phlebotomy remains the treatment of choice for hemochromatosis. In most cases of chronic hepatitis, antiviral therapy is indicated. Treatment…
View Post 9 min This content is machine translated Hepatitis C infection Therapy for all The newer therapeutics for chronic hepatitis C are now available to all infected patients regardless of fibrosis stage. DAA combinations make the disease curable in over 95% of cases.
View Post 4 min This content is machine translated General Internal Medicine Update Refresher in Zurich Drugs in gastroenterology – an update. There are recent developments in the treatment of individual gastroenterological diseases. In addition to new therapeutic options with excellent efficacy and good healing prospects for those affected, tried-and-tested groups of…
View Post 8 min This content is machine translated Hepatitis C Light at the end of the tunnel The introduction of interferon-free combination therapies with “direct acting antivirals” (DAA) was a breakthrough. Medically, therapy with current drugs can be recommended to all patients with active HCV infection. As…
View Post 4 min This content is machine translated 2nd Spring Congress of the SGAIM Viral hepatitides – how and whom to test? Hepatitis C is the “favorite child” of current medical ethics discussions. However, the new, expensive HCV drugs should not cloud the view of the overall diagnostic and therapeutic situation of…
View Post 4 min This content is machine translated Hepatocellular carcinoma Is tumor recurrence following hepatitis C therapy? The new direct-acting antiviral agents (DAAs) for the treatment of hepatitis C enable a cure in most cases. At the same time, the cost of such treatment is enormous and…
View Post 7 min This content is machine translated Hepatitis C Combating the epidemic with new knowledge More people die from hepatitis C than from HIV. Half of hepatitis C sufferers are unaware of their infection. Individuals born in the 1960s are at increased risk for hepatitis…
